Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Leukemia Supplements
|
May 14, 2016
Where are we going with CML research?
D Perrotti
British Journal of Cancer
|
September 6, 2006
ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia
D Perrotti, P Neviani
Blood
|
September 18, 1997
Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter
T Bellon, D Perrotti, B Calabretta
Cell Death and Differentiation
|
April 23, 2005
BCR/ABL, mRNA translation and apoptosis
D Perrotti, F Turturro, P Neviani
Cancer Research
|
October 15, 1991
Differential expression of transforming growth factor-beta 1 gene in 3LL metastatic variants
D Perrotti, L Cimino, S Ferrari, et al.
Journal of Lipid Research
|
April 1, 1997
Sepsis-induced regulation of lipoprotein lipase expression in rat adipose tissue and soleus muscle
S Lanza-Jacoby, N Sedkova, H Phetteplace, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1997
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity
P Salomoni, D Perrotti, R Martinez, et al.
Blood
|
November 1, 1996
A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element
D Perrotti, T Bellón, R Trotta, et al.
Cancer Research
|
May 27, 1999
Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction
E Grassilli, P Salomoni, D Perrotti, et al.
Cancer Detection and Prevention
|
January 1, 1997
Beta 4 integrin subunit expression is downregulated in low metastatic carcinoma variants
L Cimino, D Perrotti, G D'Agostino, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Leukemia Supplements
|
May 14, 2016
Where are we going with CML research?
D Perrotti
British Journal of Cancer
|
September 6, 2006
ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia
D Perrotti, P Neviani
Blood
|
September 18, 1997
Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter
T Bellon, D Perrotti, B Calabretta
Cell Death and Differentiation
|
April 23, 2005
BCR/ABL, mRNA translation and apoptosis
D Perrotti, F Turturro, P Neviani
Cancer Research
|
October 15, 1991
Differential expression of transforming growth factor-beta 1 gene in 3LL metastatic variants
D Perrotti, L Cimino, S Ferrari, et al.
Journal of Lipid Research
|
April 1, 1997
Sepsis-induced regulation of lipoprotein lipase expression in rat adipose tissue and soleus muscle
S Lanza-Jacoby, N Sedkova, H Phetteplace, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1997
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity
P Salomoni, D Perrotti, R Martinez, et al.
Blood
|
November 1, 1996
A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element
D Perrotti, T Bellón, R Trotta, et al.
Cancer Research
|
May 27, 1999
Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction
E Grassilli, P Salomoni, D Perrotti, et al.
Cancer Detection and Prevention
|
January 1, 1997
Beta 4 integrin subunit expression is downregulated in low metastatic carcinoma variants
L Cimino, D Perrotti, G D'Agostino, et al.
Page
of 4